SEC 8-K and 6-K filings classified by Claude with reasoning, plus Form 4 insider transactions. Ingested from EDGAR’s filing stream in near-real time, reconciled overnight.
Open-market buys and sells only — the deliberate trades. Zero here doesn’t mean no filings: grants, option exercises and tax withholding (below) are compensation, not market trades.
| Insider | Role | Date | Transaction | Shares | Value |
|---|---|---|---|---|---|
| Crotty Dylan Bram | Group President | 2026-08-21 | Open-market sell | 441 | $145K |
| STRYKER RONDA E | Director | 2026-08-19 | Open-market sell | 40 | $13K |
| STRYKER RONDA E | Director | 2026-08-19 | Open-market sell | 440 | $147K |
| STRYKER RONDA E | Director | 2026-08-19 | Open-market sell | 200 | $67K |
| STRYKER RONDA E | Director | 2026-08-19 | Open-market sell | 80 | $27K |
| STRYKER RONDA E | Director | 2026-08-19 | Open-market sell | 320 | $108K |
| STRYKER RONDA E | Director | 2026-08-19 | Open-market sell | 2308 | $780K |
| STRYKER RONDA E | Director | 2026-08-19 | Open-market sell | 11257 | $3.8M |
| STRYKER RONDA E | Director | 2026-08-19 | Open-market sell | 10812 | $3.7M |
| STRYKER RONDA E | Director | 2026-08-19 | Open-market sell | 16612 | $5.7M |
| STRYKER RONDA E | Director | 2026-08-19 | Open-market sell | 3274 | $1.1M |
| STRYKER RONDA E | Director | 2026-08-19 | Open-market sell | 3852 | $1.3M |
| STRYKER RONDA E | Director | 2026-08-19 | Open-market sell | 805 | $276K |
| King Debra | See Remarks | 2026-08-18 | Open-market sell | 826 | $278K |
| STRYKER RONDA E | Director | 2026-08-18 | Open-market sell | 2239 | $743K |
| STRYKER RONDA E | Director | 2026-08-18 | Open-market sell | 2920 | $971K |
| STRYKER RONDA E | Director | 2026-08-18 | Open-market sell | 8404 | $2.8M |
| STRYKER RONDA E | Director | 2026-08-18 | Open-market sell | 25536 | $8.6M |
| STRYKER RONDA E | Director | 2026-08-18 | Open-market sell | 131752 | $44.2M |
| STRYKER RONDA E | Director | 2026-08-18 | Open-market sell | 109425 | $36.8M |
Fiscal period ending 2025-12-31 versus 2024-12-31 — view filing on EDGAR →
The risk profile worsened on balance, with new concrete exposures added across tariffs, M&A integration, cybersecurity, and EU litigation, partially offset by the closure of SEC/DOJ investigations that had previously carried significant regulatory overhang. The German tax audit (2010–2017) converts a generic tax risk into a disclosed liability with interest and penalty exposure, while the Inari acquisition introduces integration and management-distraction risk. Tariff and geopolitical threats now appear in multiple themes simultaneously, signaling a broader macro-driven deterioration rather than isolated disclosures.
2 company-specific · 1 eased/removed · 4 common-mode
Added specific German tax audit (2010-2017) with material exposure, interest, penalties, and litigation risk. Concrete example escalates generic tax risk to substantive disclosed liability.
We could be negatively impacted by future changes in the allocation of income to each of the income tax jurisdictions in which we operate: We operate in multiple income tax jurisdictions both in the…
New disclosure of material 2025 Inari acquisition and integration risks, including management distraction and integration failure risk.
We may be unable to capitalize on previous or future acquisitions: In addition to internally developed products, we invest in new products and technologies through acquisitions, including our…
Prior year disclosed ongoing SEC/DOJ investigations with potentially significant impact. This year reports both agencies closed inquiries, substantially reducing regulatory risk exposure.
We are subject to federal, state and foreign healthcare regulations, including anti-bribery, anti-corruption, anti- kickback and false claims laws, globally and could face substantial penalties if we…
Added specific tariff risks and new inflation/cost-pass-through disclosure. Escalates supply chain risk from generic to concrete geopolitical and macroeconomic threats.
BUSINESS AND OPERATIONAL RISKS We use a variety of raw materials, components, devices and third-party services in our global supply chains, production and distribution processes; significant…
New explicit tariff risk added: "United States has recently enacted and proposed to enact new tariffs" with material adverse effect warning on global trade.
We rely on indirect distribution channels and major distributors that are independent of Stryker: In many markets we rely on indirect distribution channels to market, distribute and sell our…
Added geopolitical cybersecurity threat escalation and specific FDA regulatory compliance requirement (Section 524B), expanding disclosed risk scope and regulatory obligations.
We, our business partners or our third-party vendors could experience a material failure or breach of a key information technology system, network, process or site: We rely extensively on information…
New disclosure of European Representative Actions Directive creating class action regime in EU member states, expanding litigation exposure and risk.
We may be adversely affected by product liability claims, unfavorable court decisions or legal settlements: We are exposed to potential product liability risks inherent in the design, manufacture and…
Stryker issued a press release on July 30, 2026 announcing second quarter 2026 operating results, with detailed financial statements showing net sales of $6.6 billion (9.4% growth), reported EPS of $3.30 (44.1% increase), and adjusted EPS of $3.69 (17.9% increase). The filing includes consolidated statements of earnings, balance sheets, and cash flows, along with updated 2026 guidance. This is a standard quarterly earnings disclosure under Item 2.02.
View raw filing on EDGAR →Stryker announced a material reorganization of its business structure in Q1 2026, combining the orthopaedic instruments portfolio with Mako and enabling technologies into a new "Ortho Tech" business. This restructuring changes the company's segment reporting from three segments to two (MedSurg and Neurotechnology, and Orthopaedics), affecting how financial results are presented and analyzed. While the filing emphasizes this is a "recast" rather than a restatement, the organizational restructuring and resulting segment reporting changes are material operational events that would affect investor understanding of the company's business structure and performance metrics.
View raw filing on EDGAR →William E. Berry, Jr., Vice President and Chief Accounting Officer, is retiring effective September 1, 2026. While the filing also discloses Emily Baculik's appointment as his successor and compensatory arrangements for both executives, the principal disclosed action centers on Berry's departure from his officer role. The retirement of a named executive officer responsible for accounting oversight is material to investors assessing management continuity and financial reporting controls.
View raw filing on EDGAR →